{[include file="_includes/_en/user_corp500_sub_js.html"]}

  1. Home
  2. Supplier Database
  3. Major Suppliers
  4. Zhejiang Vie Science & Technology Co., Ltd.
  5. Zhejiang Vie Science & Technology Co., Ltd. Co., Ltd. Financial Data

Zhejiang Vie Science & Technology Co., Ltd. Financial Data

Consolidated

Consolidated Balance Sheet (B/S)

 (in million CNY)
  FY ended Mar. 31, 2022 FY ended Mar. 31, 2021 FY ended Mar. 31, 2020
Current assets 2,943.71 2,495.16 2,338.34
Illiquid assets 1,867.63 1,406.37 1,336.41
Total assets 4,811.34 3,901.53 3,674.75
Current liabilities 2,384.70 1,641.56 1,547.01
Illiquid debts 386.86 268.97 125.72
Total liabilities 2,771.56 1,910.53 1,672.73
Capital 479.65 479.65 479.65
Capital reserve 795.02 783.70 786.01
Profit reserve 98.41 98.05 0.10
Backlog profit 588.02 557.51 559.67
Minority stock holders' equity 76.90 72.09 78.64
Total stockholders' equity 2,039.78 1,991.00 2,002.02
Total Liabilities and shareholders' equity 4,811.34 3,901.53 3,674.75

 

Consolidated profit and loss statement

 (in million CNY)
  FY ended Mar. 31, 2022 FY ended Mar. 31, 2021 FY ended Mar. 31, 2020
Sales 3,364.06 2,713.12 2,522.05
Operating profit 67.09 (1.02) 87.83
Gross profit 66.04 7.87 87.01
Net profit 66.79 10.02 65.47



Consolidated Cash Flow

 (in million CNY)
  FY ended Mar. 31, 2022 FY ended Mar. 31, 2021 FY ended Mar. 31, 2020
Cash flows from operating activities 72.49 48.34 113.04
Cash flows from investing activities (184.89) (112.87) 14.27
Cash flows from financing activities 150.25 35.85 (119.36)
Gains and losses from exchange-rate translation 8.38 (2.29) (5.83)
Increases (decreases) in cash and cash equivalents 46.23 (30.96) 2.12
Cash and cash equivalent at the beginning of the term 510.85 541.81 539.70
Cash and cash equivalents at the term-end 557.08 510.85 541.81

Non-consolidated

Unconsolidated Balance Sheet (B/S)

 (in million CNY)
  FY ended Mar. 31, 2022 FY ended Mar. 31, 2021 FY ended Mar. 31, 2020
Current assets 1,182.58 1,299.29 1,362.20
Illiquid assets 1.520.52 1,467.59 1,442.96
Total Assets 2,703.10 2,766.88 2,805.16
Current liabilities 750.71 805.90 915.21
Illiquid debts 190.93 176.73 79.77
Total liabilities 941.63 982.62 994.98
Capital 479.65 479.65 479.65
Capital reserve 789.63 775.57 775.35
Profit reserve 75.90 75.54 75.54
Backlog profit 415.97 453.51 479.64
Total stockholders' equity 1,761.47 1,784.26 1,810.18
Total Liabilities and shareholders' equity 2,703.10 2,766.88 2,805.16

 

Unconsolidated profit and loss statement

 (in million CNY)
  FY ended Mar. 31, 2022 FY ended Mar. 31, 2021 FY ended Mar. 31, 2020 FY ended Mar. 31, 2019
Sales 1,044.42 1,245.90 1,381.40 1,182.05
Operating profit 4.80 (11.91) 94.87 186.50
Gross profit 5.50 (10.91) 94.01 184.66
Net profit 3.59 (2.15) 81.16 176.76

 

Unconsolidated cash flow

 (in million CNY)
  FY ended Mar. 31, 2022 FY ended Mar. 31, 2021 FY ended Mar. 31, 2020
Cash flows from operating activities 150.65 42.04 100.67
Cash flows from investing activities (70.53) (147.12) 2.69
Cash flows from investing activities (61.20) (15.94) (408.81)
Gains and losses from exchange-rate translation 8.13 (2.40) (6.05)
Increases (decreases) in cash and cash equivalents 27.05 (123.41) (311.50)
Cash and cash equivalent at the beginning of the term 223.65 347.06 359.06
Cash and cash equivalents at the term-end 250.71 223.65 47.56
Source : The Company's annual reports (data based on Chinese accounting standards)
Fiscal years ending in Dec. 31.